Welcome to the November edition of the OBN Monthly Newsletter.
Isansys Lifecare partners with WH Tech in Australia
Isansys Lifecare , a global digital health technology company, is delighted to announce its partnership with WH Tech Pty Ltd, Australia’s leading importer of wearable connected healthcare.

WH Tech will be offering the Patient Status Engine, Isansys’ real-time and predictive patient data capture and analysis platform to the Australian healthcare markets.

Ben Magid, the Chief Technology Officer at WH Tech who spent time at the Isansys’ head office in the UK earlier this year for a strategy planning meeting: said:"...This is the first time anywhere in the world that clinicians will have real time oversight of every patient simultaneously.”
OBN News:
Congratulations to all our 2019 OBN Award winners!

The 2019 OBN Awards event was a glittering evening where the winners of the prestigious awards were presented in front of an audience of over 270 life science industry leaders, at the Examination Schools in Oxford. 

The Awards, which are in their 11 th  year, celebrate the best of UK life sciences – from outstanding scientific innovation within Biotech, Medtech and Digital Health, to the companies that support the industry and the fundraisers that make it happen. We received a record number of quality entries again this year, and competition was tight in all categories, and represents a true reflection of how buoyant the life sciences industry continues to be.

Many congratulations to our award winners and a huge thank you to all our sponsors, event host and keynote speaker, and to all those who joined us on the night to celebrate with us. To see the full Press Release with the award winners please click here . Also, photos from the evening are now available on our website www.obn-awards.com
Keen to Raise your Profile?

Consider presenting at BioLaunchPad , the company showcase platform of BioTrinity, where R&D companies, TTO's and anyone else wishing to share their commercial proposition can do so via our packed schedule of back to back 5-minute presentations. Make the most of your 5-minutes by ensuring you only cover key information about your company, the challenges you face, how you plan to overcome them and what are your opportunities for growth.

BioLaunchPad presentation slots are complimentary for all pre-vetted R&D companies who wish to take part. To apply for a presentation simply register for a delegate ticket and email your 'request to present' to the  BioTrinity Events Team  FAO Sarah Walker.

Early bird delegate tickets  are now on sale, for a limited time and cost  £700  plus VAT for OBN members and  £1,000  plus VAT for non-Members. Please click here to register.

"BioTrinity offers the opportunity to take great ideas and intelligent financing and combine them into a launchpad."
Connect is Launched!

Check out the first edition of OBN's new ' CONNECT ' magazine.

CONNECT is OBN's twice yearly magazine, first published in Autumn 2019. It provides a range of high quality news items from contributors within the industry in areas such as regulation, recruitment, finance and big pharma, with the intention of always generating an informative, interesting, and stimulating read. It also provides a listing of current OBN Members by sector. We hope that you enjoy it!
tend not to read much more than a couple of paragraphs. Place article copy here.
Who is in the OBN Spotlight ?

This month Susan Ingledew is in the OBN spotlight!

"I joined OBN 5 years ago as Executive Assistant and, more recently Business Support Manager. The role is really varied, which I love, I’m the first point of contact for all things HR, H&S, IT, compliance, procedures as well as providing Exec Assistant support to the CEO, the Board and our Investment & Tax Special Interest Group.
 
Most of my spare time is spent at exercise classes – Clubbercise (complete with glowsticks), Boxfit, Body Balance and Pilates; I occasionally drive my colleagues crazy when I’m dancing enroute to the copier and waiting for the kettle to boil! I’m married and we have a little dog (our furbaby) who we both adore."
Welcome to our new Members:
Model-Informed Drug Discovery and Development Augmented by AI
Manufactures materials for medical devices and regenerative medicine
Pursuing drugs that target acid-sensing GPCRs on cells of the adaptive and innate immune systems
Go to the  OBN website and login  to view the details of discounts  you can receive as an OBN Member to attend a wide range of events, or contact membership@obn.org.uk  
Contact  Lee Pratley  to find out how you can make huge savings on Lab and office supplies, business travel, utility bills and our new Purchasing Platform.
Supplier Offers:
Don't miss out! As an OBN Full Member you can access on average a  45% discount  from the Corning® equipment by clicking on the button below
 
This amazing offer is valid until 31st January 2020 so place your orders today by going to  www.sigmaaldrich.com 
Other Events and News:
Learn how to get Phase I Materials to Clinic in 14 weeks
Join Thermo Fisher Scientific on 4 December at Milton Park for an interactive lunch and learn session about a strategic approach to your oral solid dose development.  This exclusive session is only open to 20 registrants who are OBN Members and will receive Apple AirPods and complimentary car service to the site.*
Industry experts Helen Underwood, Director of Strategic Client Relationships, and Kaspar Van Dries, Senior Director of Science & Innovation, will share insights and answer questions about:

  • Managing complexity, speed and quality for phase-appropriate formulation
  • Addressing early phase pain points
  • Managing cycle times
  • Optimizing output for scalability 

Please c lick here to Register.
Clinical Innovators Summit UK

Wednesday 4 December from 2pm – 6pm at The Oxford Science Park.
To register your FREE place please click her e
AIMday Neurotechnology

The University of Oxford is hosting an AIMday in Neurotechnology on Thursday 26 March 2020 .

The AIMday will bring together academic and clinical excellence from across the University of Oxford together with industry to help answer the most pressing challenges in this area, as identified by industry.

This event is open to all companies working in this area, both large and small. The AIMday series of events provide a low barrier route, particularly for SMEs, to engage with a wide range of academics at the University.

FREE registration for companies is now open and closes on Friday 20 December. 
o2h Ventures has launched Britain's first S/EIS investment fund backing biotech therapeutic and related AI opportunities. The geographic scope is UK wide including Oxford and London but will target the growing Cambridge biotech cluster.
 
Large pharmaceutical companies, such as GSK, AstraZeneca and Pfizer have moved from developing innovation in-house to acquiring innovation externally, forcing up prices for the best science and providing earlier exit opportunities. 

The team at o2h have access to some of the most exciting ideas through its live grass roots working relationships fostered with entrepreneurs and scientists over many years giving it far earlier access than competitors to the most promising companies. Sunil Shah, CEO, was recently awarded the UKBAA ‘Angel Investor of the Year’ and the 2019 OBN Special Recognition Award.

For more information, please visit www.o2hventures.com or email invest@o2h.com
Join Us!

If you haven't already joined OBN please take a look at all the benefits of becoming an OBN Member and join today!! If you have any questions then please contact Nicola Westgate , Membership Manager.

If you have any News, Jobs or Events you would like to share with OBN Members and Contacts, please email  Rebecca Wilkes , Communications and Marketing Coordinator, with the details .
Thank you to all our OBN Sponsors